Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 2, Status: Authorised
EMA celebrates 30 years of progress in science and medicines in the European Union
Human medicines European public assessment report (EPAR): Apixaban Accord, apixaban, Date of authorisation: 23/07/2020, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Izba, travoprost, Date of authorisation: 20/02/2014, Revision: 8, Status: Authorised
Pregabalin Accord : EPAR - Risk management plan
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 23, Status: Authorised
CHMP opinions on consultation procedures
Medicinal products for human use: Monthly figures - December 2024
Veterinary medicinal products for zootechnical purposes - Scientific guideline